A Prospective Observational Study of Foam Sclerotherapy .

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT04111692
Status
Recruiting
Apply to this trial

Conditions

  • Autosomal Dominant Polycystic Kidney
  • Autosomal Dominant Polycystic Liver Disease
  • Hepatic Cyst
  • Renal Cyst

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Study Details

An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/liver cyst volumes at up to 12 months of follow-up in patients with autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD).

Key Dates

Start date
Nov 6, 2017
Status verified
Jan 2026
Primary completion
Nov 30, 2027
Completion
Nov 30, 2027

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Change in Pain Inventory [ Time Frame: Baseline, 1 month, 6 month, 12 month ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Marie C Hogan, MD, PhD
[email protected]
507-266-1963
Marie C. Hogan, M.D., Ph.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Clinic· Rochester, MN

Related Studies